← Leaderboards
Stephen Anderson
$28,980
Attributed
$28,980
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $12.4K · FY2021–23$20K$15K$10K$5K$0
'21
'22
'23
Funding mix
By agency
NIH$28,980 · 1
By mechanism
N02$28,980 · 1
Top collaborators
No co-investigators on record.
Others in their field
Other Emerging Leaders on “Analytical Method”
- John E West · University Of Texas At Austin$94,000,000
- Gautam (george) Mitra · Leidos Biomedical Research, Inc.$53,523,213
- Leonard Freedman · Leidos Biomedical Research, Inc.$34,953,667
- Bala Raja · Luminostics, Inc.$28,624,460
- Greg Yothers · University Of Chicago$25,122,895
- Emmanuel Aja Oga · Research Triangle Institute$16,110,065
Research focus
Analytical MethodFeedbackAssay DevelopmentChemistryAuthorityChronic Musculoskeletal PainClinical PainClinical ResearchClinical TrialsConduct Clinical TrialsChronicContractorContractsDesignDoseDrug DevelopmentDrug DiscoveryDrug KineticsDrug MetabolismElectronic MailEnsureEuropeanExperimental DesignsFormulation
Grant awards (3)
PHARMACEUTICS/FORMULATION/CMC CONSULTING SERVICES FOR NINDS HEAL PROGRAM$12,420
N02 · FY2023 · DA · contact PI
PHARMACEUTICS/FORMULATION/CMC CONSULTING SERVICES FOR NINDS HEAL PROGRAM$4,140
N02 · FY2022 · DA · contact PI
PHARMACEUTICS/FORMULATION/CMC CONSULTING SERVICES FOR NINDS HEAL PROGRAM$12,420
N02 · FY2021 · DA · contact PI